Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an Example

Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an Example

Alhanouf Yousef Alnafisah,1 Ahmed Fawaz Alkhalidi,1 Hanin Aljohani,1 Manal Almutairi,1 Adel Alharf,2 Hadeel Alkofide3 1Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia; 2Drug Sector, Saudi Food and Drug Aut...

Full description

Bibliographic Details
Main Authors: Alnafisah AY, Alkhalidi AF, Aljohani H, Almutairi M, Alharf A, Alkofide H
Format: Article
Language:English
Published: Dove Medical Press 2024-05-01
Series:Clinical Epidemiology
Subjects:
covid-19
outcome measures
non-hospitalized patients
monoclonal antibodies
and antiviral agents
Online Access:https://www.dovepress.com/hospitalization-endpoint-in-clinical-trials-of-outpatient-settings-usi-peer-reviewed-fulltext-article-CLEP

Internet

https://www.dovepress.com/hospitalization-endpoint-in-clinical-trials-of-outpatient-settings-usi-peer-reviewed-fulltext-article-CLEP

Similar Items